Adult mouse intrahepatic biliary epithelial cells induced in vitro to become insulin-producing cells
JOURNAL OF ENDOCRINOLOGY
Authors: Nagaya, Masaki; Katsuta, Hitoshi; Kaneto, Hideaki; Bonner-Weir, Susan; Weir, Gordon C.
Abstract
Transdifferentiation of cells from a patients own liver into pancreatic beta-cells could be useful for beta-cell replacement. We hypothesized that intrahepatic biliary epithelial cells (IHBECs) could become a new source of insulin-producing cells. IHBECs isolated from adult mice were expanded using our novel culture method termed, collagen-embedded floating culture method (CEFCM). With CEFCM, IHBECs formed three-dimensional ductal cysts and rapidly expanded their number by about 15-fold within 2 weeks. Over 90% of cells were positive for cytokeratin 7 and 19. At day 14, IHBECs were transfected with adenoviral (Ad)- pancreas duodenum homeobox 1 (Pdx-1), NeuroD or Pdx-1/VP16. After 7 additional days in serum- and insulin-free differentiation medium (DM), cell phenotypes were determined by RT-PCR, immunostaining and ELISA for insulin. In DM control IHBECs started to express some endocrine progenitor genes (Neurog3, NeuroD, Nkx6.1, and Pdx-1) but lacked insulin gene (Ins) mRNA. Transduced expression of PDX-1, NEUROD or PDX-1/VP16 led to expression of not only INS but also GLUT2 and prohormone convertase 1 and 2. About 3% of 4000 cells counted in PDX-1/VP16 transduced cultures stained strongly for C-peptide Suggesting that a subpopulation may have the capacity for differentiation. Transduced cells released insulin (Ad-PDX-1 0.08 +/- 0.05, Ad-NEUROD 0.33 +/- 0.09, Ad-PDX-1/VP16 0.37 +/- 0-14 ng/1 x 10(5) cells after 48 h in Culture). IHBECs can be markedly expanded, and then with molecular manipulation a subpopulation of these cells can differentiate towards a beta-cell phenotype. This approach may lead to a new source of beta-cells that can be used for transplantation in diabetes. Journal of Endocrinology (2009) 201, 37-47
Fetal androgen signaling defects affect pancreatic beta-cell mass and function, leading to glucose intolerance in high-fat diet-fed male rats
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Authors: Harada, Naoki; Yotsumoto, Yusuke; Katsuki, Takahiro; Yoda, Yasuhiro; Masuda, Tatsuya; Nomura, Masayuki; Shiraki, Nobuaki; Inui, Hiroshi; Yamaji, Ryoichi
Abstract
We previously demonstrated that androgen signaling expands pancreatic beta-cell mass in the sexual maturation period (Am J Physiol Endocrinol Metab 314: E274-E286, 2018). The aim of this study was to elucidate whether fetal androgen signaling plays important roles in beta-cell mass development and beta-cell function in adulthood, defects of which are associated with type 2 diabetes mellitus. In the pancreas of male fetuses, androgen receptor (AR) was strongly expressed in the cytoplasm and at the cell membrane of Nkx6.1-positive beta-cell precursor cells but was markedly reduced in insulin-positive beta-cells. Administration of the anti-androgen flutamide to pregnant dams during late gestation reduced beta-cell mass and Ki67-positive proliferating beta-cells at birth in a male-specific manner without affecting body weight. The decrease of beta-cell mass in flutamide-exposed male rats was not recovered when rats were fed a standard diet, whereas it was fully recovered when rats were fed a high-fat diet (HFD), at 6 and 12 wk of age. Flutamide exposure in utero led to the development of glucose intolerance in male rats due to a decrease in insulin secretion when fed HFD but not standard diet. Insulin sensitivity did not differ between the two groups irrespective of diet. These results indicated that the action of fetal androgen contributed to beta-cell mass expansion in a sex-specific manner at birth and to the development of glucose intolerance by decreasing the secretion of insulin in HFD-fed male rats. Our data demonstrated the involvement of fetal androgen signaling in hypothesized sex differences in the developmental origins of health and disease by affecting pancreatic beta-cell function.